The content on this page is provided for reference purposes only. It was current when produced, but is no longer maintained and may be outdated.
Availability of Tamiflu for Oral Suspension (12/11/2009)
Updated Safety Information about a drug interaction between Clopidogrel Bisulfate (marketed as Plavix) and Omeprazole (marketed as Prilosec and Prilosec OTC) (11/17/2009)
The FDA recommends that consumers should not use body building products marketed as containing steroids or steroid-like substances (7/28/2009)
FDA Requires New Boxed Warnings for the Smoking Cessation Drugs Chantix and Zyban (7/1/2009)
Loss of Sense of Smell with Intranasal Cold Remedies Containing Zinc (06/16/2009)
Public Health Advisory: Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings (03/05/2009)
FDA issues Updated Safety Information about Raptiva (efalizumab) (02/19/2009)
Potential Hazards of Skin Products Containing Numbing Ingredients for Relieving Pain from Mammography and Other Medical Tests and Conditions (01/16/2009)
Page Last Updated: 08/19/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.